⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CMND News
Clearmind Medicine Inc. Common Shares
Clearmind Medicine Announces Publication of Six Innovative Patents in Hong Kong for Next-Generation Psychedelic-Based Combination Therapies
globenewswire.com
CMND
Clearmind Medicine Announces Publication of Six Innovative Patents in Hong Kong for Next-Generation Psychedelic-Based Combination Therapies
globenewswire.com
CMND
Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy
globenewswire.com
CMND
SPRC
Clearmind Medicine Advances Recruitment for CMND-100 Trial's Third Cohort at Yale, Johns Hopkins and Tel Aviv Sites Following Recent Positive Topline Results
globenewswire.com
CMND
Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
globenewswire.com
CMND
SPRC
Clearmind Medicine Moving Forward to the Next Stage of Its Clinical Trial Following Data and Safety Monitoring Board Approval
globenewswire.com
CMND
Clearmind Medicine Moving Forward to the Next Stage of Its Clinical Trial Following Data and Safety Monitoring Board Approval
globenewswire.com
CMND
LDB Capital Corp. Announces Definitive Agreement for Proposed Qualifying Transaction with Eventer Technologies Ltd. Ready to Announce with Confidence?
newsfilecorp.com
PLRZ
CMND
ODYS
JFBR
Moonage Media Review: Clearmind's MEAI and GLP-1 - Are These the Next-Generation Treatment for Weight Loss?
prnewswire.com
CMND
Clearmind Medicine Announces Additional Topline Positive Safety Results Reinforcing Favorable Profile of CMND-100 in Ongoing Phase I/IIa Clinical Trial
globenewswire.com
CMND